Recent News for GBT - Global Blood Therapeutics, Inc.

Date Title
Dec 10 Global Blood Therapeutics, Voxelotor in Advanced Clinicals, Analysts Review and Target
Dec 8 Global Blood Therapeutics: Can The Rally Continue?
Dec 7 Global Blood prices stock offering; shares down 6% premarket
Dec 7 Global Blood Therapeutics Prices a $150.0 Million Common Stock Public Offering
Dec 7 JP and BIG among premarket losers
Dec 7 The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut
Dec 7 3 Biotech Stocks That Could Explode Higher in 2019
Dec 7 Global Blood Therapeutics Delivers The Good News; What Is The Path Ahead?
Dec 6 Global Blood launches $150M stock offering; shares down 4% after hours
Dec 6 Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
Dec 6 3 Top Stocks After #ASH18
Dec 6 Global Blood Therapeutics Gets A Quick Advance Surprise By The FDA
Dec 5 Jim Cramer Advises His Viewers On Adobe, Barnes & Noble And More
Dec 4 Cramer's lightning round: Barnes & Noble's stock is trading like it could get acquired
Dec 4 Company News For Dec 4, 2018
Dec 4 Stocks Jump 1% on 90-Day Tariff Delay
Dec 4 Global Blood Therapeutics' Voxelotor on Faster Approval Path
Dec 4 Today's Research Reports on Trending Tickers: Regeneron Pharmaceuticals and Global Blood Therapeutics
Dec 3 Mid-Afternoon Market Update: Tesaro Climbs On Acquisition News; Tonix Pharmaceuticals Shares Slide
Dec 3 Global Blood's voxelotor shows positive action in late-stage sickle cell study; shares up 56%
Dec 3 Healthcare and Industrial goods dominate midday movers
Dec 3 46 Stocks Moving In Monday's Mid-Day Session
Dec 3 Mid-Day Market Update: Hexindai Falls After Q2 Results; Global Blood Therapeutics Shares Surge
Dec 3 Global Blood's Sickle Cell Disease Drug Snags Accelerated FDA Approval Pathway
Dec 3 Tesaro leads Healthcare gainers; Aphria and Tonix Pharmaceuticals among losers

Back to the Main GBT Page...